Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.

Search

News

BioVaria Spin-off Awards go to Charité spin-off and Braingineering Technologies

19 May 2016, Munich, Germany – Dealmakers and investors from the…

Cancer-fighting gene therapy

As a member of the TechnologieAllianz – the German association for knowledge and technology transfer – Ascenion warmly invites you to attend the…

A ground-breaking approach to the therapy of HIV infection has been published in the current issue of Nature Biotechnology: a designer recombinase…

BioVaria is designed for dealmakers and investors from the global life-science sector responsible for identifying, licensing or funding break-through…

Flexible funds from technology transfer

WIPANO (Wissenstransfer durch Patente und Normen: knowledge transfer via patents and standards) is the successor to SIGNO, and has been running since…

In our current newsletter you can read about projects that benefit from LifeScience Foundation grants, and discover what a former industry manager who…

Merry Christmas!

We’d like to thank all our clients, colleagues and partners in technology transfer, research and industry for the enjoyable and productive…

The first clinical trial of MSOT, iThera’s innovative imaging technique, has made it onto the cover of the prestigious journal Science Translational…

The US biotech company Amgen announced at the end of November that its cancer therapy BLINCYTO® has been approved by the European Commission for the…

From 40 submitted projects – all excellent, according to the jury – five have now emerged as winners. These were chosen as having the potential to…

TechnologieAllianz announced the acquisition of seven new members at the beginning of December, including Ascenion. The association for knowledge and…

amcure, a spin-off from the Karlsruhe Institute of Technology (KIT), has received a further EUR 1.9 million funding from the German Federal Ministry…

Ascenion’s portfolio company OMEICOS, a spin-off from the Max Delbrück Center for Molecular Medicine (MDC) in Berlin, has received further funding of…

Events